Skip to content
HealthMinute.TV

HealthMinute.TV

  • Home
  • Derm.City
  • Derm.Business
  • Chronicle Companies
  • Contact
January 5, 2022January 4, 2022 chroniclepublishing Dermatology

Study shows higher doses of upadacitinib produce added benefit in moderate-to-severe AD

Higher doses of upadicitinib show added benefits for adults with moderate-to-severe atopic dermatitis (AD) when compared to dupilumab, according to a new study.

December 15, 2021 chroniclepublishing Dermatology

New study finds AD patients may be at greater risk of systemic and psychiatric comorbidities

According to a new study, adults with atopic dermatitis (AD) have a higher incidence of systemic, autoimmune, and psychiatric comorbidities than those without AD.

December 8, 2021 chroniclepublishing Dermatology

New study shows AD patients on dupilumab may experience less severe Covid-19 symptoms

Patients being treated with dupilumab for atopic dermatitis (AD) may experience less severe Covid-19 symptoms, according to a new study.

December 2, 2021 chroniclepublishing Dermatology

Pre-pregnancy obesity may be linked to increased risk of AD in infants, study finds

New research has suggested that intrauterine mechanisms of overweight women in pre-pregnancy may have increased risks of their infants having atopic dermatitis (AD).

November 24, 2021 chroniclepublishing psoriasis

New study links key protein to inflammation in psoriasis patients

Researchers have linked a key protein called TWEAK to inflammation in psoriasis patients. 

November 17, 2021 chroniclepublishing psoriasis, research

Risankizumab worsened symptoms in patients with severe asthma, new study finds

A new study tested risankizumab, approved for the treatment of psoriasis, in patients with severe asthma and found it worsened their asthma symptoms.

November 10, 2021 chroniclepublishing Dermatology, psoriasis

Researchers gather real world treatment data on psoriatic arthritis patients

Researchers have surveyed 137 respondents from a psoriatic arthritis (PsA) registry for phenotypic features and characteristics, initial and current therapies, and medication preference.

November 3, 2021 chroniclepublishing Skin Care

Dupilumab linked to reduced itch in prurigo nodularis patients, according to study

Results of a phase 3 trial have linked dupilumab to significantly reduced skin lesions and itch when compared to placebo in adult prurigo nodularis patients, according to a press release (Oct. 22, 2021).

October 27, 2021 chroniclepublishing research, Wounds

Research finds that movement of skin stem cells linked to skin regeneration

Researchers have found that skin regeneration is associated with the ability of skin stem cells to move toward the injury.

October 20, 2021 chroniclepublishing research

Researchers develop technique for visualizing melanocytes in 3D

Researchers have developed a technique that allows the 3D visualization of every cell containing melanin in whole zebrafish. Using X-ray imaging, the researchers were able to obtain quantitative measurements and map the location of each melanocyte.

Posts navigation

Older posts
Newer posts
Create a website or blog at WordPress.com
HealthMinute.TV
Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    • HealthMinute.TV
    • Join 63 other subscribers
    • Already have a WordPress.com account? Log in now.
    • HealthMinute.TV
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    Design a site like this with WordPress.com
    Get started